Golden State Equity Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Golden State Equity Partners's AMGN Position: Q2 2026 in Review
Golden State Equity Partners sold out of Amgen (AMGN) in Q2 2026, closing a stake of 13,541 shares — an estimated $4.76M sold.
Golden State Equity Partners first reported a position in AMGN in Q4 2020 and held it in 18 quarters. The position peaked at $4.76M in Q1 2026. 1,764 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Golden State Equity Partners reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
- Golden State Equity Partners sold 13,541 Amgen shares in Q2 2026, an estimated $4.76M.
- Golden State Equity Partners first reported a position in Amgen in Q4 2020 and held it in 18 quarters.
- Golden State Equity Partners's Amgen position peaked at $4.76M in Q1 2026.
- 1,764 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Golden State Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.